| Stereochemistry | ACHIRAL |
| Molecular Formula | C13H25NO2 |
| Molecular Weight | 227.3431 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CCOC(=O)CCC1CCCCC1
InChI
InChIKey=MPOYJPINNSIHAK-UHFFFAOYSA-N
InChI=1S/C13H25NO2/c1-14(2)10-11-16-13(15)9-8-12-6-4-3-5-7-12/h12H,3-11H2,1-2H3
| Molecular Formula | C13H25NO2 |
| Molecular Weight | 227.3431 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Cyprodenate is a stimulant drug, developed by the French company Les Laboratoires Albert Rolland. Cyprodenate was used in the clinical practice to correct the tranquilizing action of benzodiazepine drugs. Upon administration, cyprodenate is hydrolyzed to produce dimethylethanolamine (deanol), which is a precursor of choline, and may enhance central acetylcholine formation.
